Latest Ai Innovation News

Page 2 of 8
Intelligent Monitoring Group (IMG) reported robust FY25 results with $38.4m EBITDA and an 8.2% earnings rise, while projecting up to 24% EBITDA growth in FY26 fueled by AI innovations and key acquisitions.
Victor Sage
Victor Sage
10 Nov 2025
BrainChip Holdings Ltd has launched a fully underwritten $35 million placement alongside a $2 million share purchase plan to fund the commercialization of its Akida 2.0 technology and new TENNs product development. The capital raise underscores the company’s commitment to expanding its footprint in the rapidly growing edge AI market.
Sophie Babbage
Sophie Babbage
10 Nov 2025
BrainChip Holdings Ltd has secured A$35 million through a fully underwritten placement and an additional A$2 million via a Share Purchase Plan to fast-track its neuromorphic AI technology and product development.
Sophie Babbage
Sophie Babbage
10 Nov 2025
Algorae Pharmaceuticals has launched AlgoraeOS Version 2, a major AI platform upgrade that surpasses leading models including those from Google DeepMind, promising to accelerate drug-combination discovery.
Ada Torres
Ada Torres
10 Nov 2025
Integral Diagnostics has appointed Jason Martinez as its new CEO, set to lead the company’s growth and innovation efforts starting in 2026. Martinez brings over two decades of diagnostic imaging leadership experience, promising a strategic focus on expansion and operational excellence.
Ada Torres
Ada Torres
10 Nov 2025
Block, Inc. reported robust Q3 2025 results, driven by strong Cash App and Square performance, and raised its full-year guidance. The company’s AI innovations and expanding BNPL offerings are key growth engines.
Sophie Babbage
Sophie Babbage
7 Nov 2025
FirstWave Cloud Technology reports a cash-flow positive quarter with a $2.85 million capital raise and advances its AI-powered compliance product, targeting a commercial release by November.
Sophie Babbage
Sophie Babbage
31 Oct 2025
Cluey Ltd reported a stable Q1 FY26 revenue of $7.4 million alongside its strongest-ever underlying EBITDA, as it accelerates investment in AI-driven educational products set to launch in 2026.
Victor Sage
Victor Sage
31 Oct 2025
Echo IQ Limited has advanced its EchoSolv heart failure solution towards FDA submission, driven by a landmark clinical validation study and a sharp rise in US platform adoption. Strategic partnerships and international expansion efforts underscore the company’s growing footprint in cardiology AI.
Ada Torres
Ada Torres
30 Oct 2025
Nanoveu’s subsidiary EMASS has partnered with Arrow Electronics to accelerate the deployment of its ultra-low-power ECS-DoT edge AI chip, aiming to simplify always-on AI integration across multiple industries.
Sophie Babbage
Sophie Babbage
29 Oct 2025
Algorae Pharmaceuticals has broadened its commercial footprint in Australia and New Zealand through key licensing agreements, while advancing its AI-driven drug discovery platform and strengthening leadership.
Victor Sage
Victor Sage
28 Oct 2025
XPON Technologies reports a robust Q1 FY26 with 17.5% revenue growth, positive cash flow, and strategic leadership changes, setting a strong foundation for the year ahead.
Sophie Babbage
Sophie Babbage
28 Oct 2025